Stay updated on PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page.

Latest updates to the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedNapoli, Italy, 80131 was replaced with Naples, Italy, 80131 in the location details. The revision tag changed from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check13 days agoChange DetectedNew investigators and updated contact details were added, and the study locations were updated to 76. Several investigators were removed in the update.SummaryDifference0.4%

- Check20 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check28 days agoChange DetectedAdded a new NEJM publication citation to the Publications section for the rezatapopt Phase 1 study, listing authors including Dumbrava et al. and DOI 10.1056/NEJMoa2508820.SummaryDifference0.0%

- Check42 days agoChange DetectedAdded University of San Diego Moores Cancer Center in La Jolla, CA, with investigator Shumei Kato, MD, and noted the study status as Terminated/Withdrawn. Removed the Chicago, IL site (Robert H. Lurie Comprehensive Cancer Center) and investigators Devalingam Mahalingam, MD, PhD and John Kaczmar, MD, along with the contact Martin Sebastian, MD.SummaryDifference1%

- Check49 days agoChange DetectedMinor CMS revision from v3.4.0 to v3.4.1 with no observed impact on the study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PC14586 in TP53 Y220C+ Solid Tumors Clinical Trial page.